Ledger.Open graph →
SEC Form D · filed June 16, 2017

Checkmate Pharmaceuticals, Inc

Offering
$27.0M
Sold
$27.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Corey M. Goodman · Cambridge, MADirectorCharles M. Yon · Cambridge, MAExecArthur M. Krieg · Cambridge, MAExec · DirectorDavid M. Mauro · Cambridge, MAExecMichael J. Powell · Billerica, MADirectorBen M. Auspitz · Cambridge, MADirectorDonald P. Martin · Reston, VAExecRick L. Ryan · St. Louis, MOExecC. R. Mullet · Reston, VADirectorJack Honour · Las Vegas, NVExec · DirectorDavid A. Smoller · St. Louis, MODirectorClifford K. Holekamp · St. Louis, MODirectorCharles M. Abdalian · CAMBRIDGE, MAExecRamani M. Varanasi · CAMBRIDGE, MAExecArthur Reidel · San Martin, CADirectorGerald Fitch · Newport Coast, CAExecAhmad Atwan · New York, NYDirectorAndrew Medvedev · New York, NYDirectorJames Wilmott · New York, NYExecSteve Berman · Atlanta, GAExec · DirectorCharles M. Abdalian · CAMBRIDGE, MAExecRamani M. Varanasi · CAMBRIDGE, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗